It would be interesting to investigate the possible regulatory mechanisms of FRAS1 modification by erasers enzymes such as FTO, which will be performed in our further project and enrich the regulatory mechanism mediated by FRAS1 in NSCLC. The gene discussed is FRAS1; the disease is non-small cell lung carcinoma.